在母乳养期间使用组合激素避孕-对医生建议的调查
Lior Segev1,2, Gideon Weitzman2, Goldie Katz-Samson3
1Azrieli Faculty of Medicine, Bar Ilan University, Safed 1311502, Israel.
Journal of clinical medicine
|November 25, 2023
概括
由于牛奶产量问题,医生经常犹在母乳养期间开组合激素避孕药 (CHC). 然而,在母乳养建立后,CHC是安全的,这凸显了需要更好地教育医生,以了解其对治疗突破性出血的益处,而不是仅含孕激素的药丸 (POPs).
科学领域:
- 生殖健康 生殖健康
- 避孕药是一种避孕药,用于避孕.
- 产后护理 产后护理
背景情况:
- 在初始母乳养期间,建议服用仅含孕激素的避孕药 (POP),因为人们担心使用组合激素避孕 (CHC) 产生的牛奶.
- 与POPs一起的突破性出血 (BTB) 经常导致停止治疗,尽管CHC的确立的安全概况是母乳养后的建立.
- 在已确定的母乳养期间,关于CHC的安全性和有效性的知识差距存在.
研究的目的:
- 评估医生对母乳养期间组合激素避孕 (CHC) 安全性的看法.
- 评估医生是否愿意在孕激素单片药 (POPs) 上给患有突破性出血 (BTB) 的哺乳妇女开处方CHC.
- 确定医生对产后患者中CHC使用的担忧和决策因素.
主要方法:
- 一个在线问卷调查了112名医生,询问他们对母乳养妇女的CHC处方习惯.
- 参与者被问及涉及妇女产后三个月,完全母乳养和经历POPs上的BTB的场景.
- 记录了医生的感知风险和处方CHC的条件.
主要成果:
- 接受调查的医生中有一半会给乳房哺乳期的妇女开处方;28%会等到产后六个月,14%不会在母乳养期间开处方.
- 医生对母乳养期间使用CHC的主要担忧是母乳产量可能减少 (88%).
- 很大一部分医生表现出知识上的差距,只有一半的医生承认CHC对POPs的好处,用于在已建立的母乳养中管理BTB.
结论:
- 医生态度显示,与卫生组织关于CHC与母乳养后 (5-6周) 的兼容性指导方针存在差异.
- 加强医生教育对于解决安全问题和促进CHC作为哺乳期妇女经历POP副作用的可行选择至关重要.
- 在母乳养成熟后 (例如,产后30天) 处方CHC可以通过提供与令人烦的BTB的POPs的替代方案来改善避孕方式的遵守.
相关概念视频
Birth Control Methods
272
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
272
Hormonal Regulation of the Menstrual Cycle
403
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
403
Target Cell Response to Hormones
3.1K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
3.1K
Gonadal and Placental Hormones
1.5K
The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair...
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair...
1.5K
Drug Dosage Regimen: Overview
3.6K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.6K
Dosage Regimen: Fixed Dose
1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K


